4
Changes in Ownership
Silence Therapeutics plc Filed Acc 0002048873-25-000005
Options or other derivatives
- Director acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ede-Golightly James Director | 2025-12-22 | Grant or award · Share Option (Right to Buy) | +90,000 | 90,000 | D: show line 1 in the form |
Loading xslF345X05/form4-12222025_111219.xml…